contract_awardAwarded Tuesday, July 14, 2026Analyzed

GLAXOSMITHKLINE, LLC: $793M Department of Health and Human Services Contract Vehicle

Neutral

Summary

This contract is a $793 million indefinite delivery/indefinite quantity award to GlaxoSmithKline, LLC for vaccines under the Vaccines for Children program for FY25. The recipient is a private entity, so there is no direct public company beneficiary, but the contract underscores the ongoing federal commitment to pediatric vaccination programs.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.GlaxoSmithKline, LLC is a private entity, so no public company directly books this $793M contract.
  • 2.The Vaccines for Children program is a recurring federal initiative, reinforcing steady demand for pediatric vaccines.
  • 3.Investors should monitor for subcontracting opportunities or supply chain contracts that may involve publicly traded firms.

Market Implications

Since the contract recipient is private, there is no direct equity impact. The broader healthcare sector remains supported by consistent federal vaccine spending, but without a specific public company tied to this award, market implications are muted. Investors may look to other publicly traded vaccine makers for similar contract opportunities, but this particular award does not change their prospects.

Full Analysis

The Department of Health and Human Services, through the CDC, awarded GlaxoSmithKline, LLC a $793 million contract for the Vaccines for Children (VFC) program for FY25. The VFC program provides vaccines to children who are uninsured, underinsured, or eligible for Medicaid. GlaxoSmithKline, LLC is a private entity, meaning no publicly traded company directly captures this revenue. However, the contract signals sustained government spending on childhood immunization, which supports the broader healthcare sector, particularly vaccine development and distribution infrastructure. The contract is structured as an indefinite delivery/indefinite quantity, typical for multi-year procurement, and runs from April 2025 to March 2026. Despite its large size, this is a routine annual renewal for a well-established program, not a new initiative. No bill signals from the provided list directly relate to this contract, and the private nature of the recipient limits direct public market implications. Historically, the VFC program has been a stable funding stream for vaccine manufacturers, but in this case, the benefit accrues to a private company, leaving no straightforward equity play.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Exec OrderAug 6, 2026

Ending Birth Tourism

This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.

Contract Details

Recipient

GLAXOSMITHKLINE, LLC

Award Amount

$793,016,570

Awarding Agency

Department of Health and Human Services

Sub-Agency

Centers for Disease Control and Prevention

Contract Type

INDEFINITE DELIVERY / INDEFINITE QUANTITY

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →